Skip to content

Current ratio at other companies

Baxter International logo
Baxter InternationalBAX
1.9×-0.2×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
0.9×-0.2×
Embecta Corp. logo
Embecta Corp.EMBC
2.5×0.0×
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
3.8×+0.9×
InfuSystem Holdings logo
InfuSystem HoldingsINFU
2.1×-0.1×
UFP Technologies logo
UFP TechnologiesUFPT
2.9×+0.3×

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Return on equity-13.7%-4.8pp
Debt / equity0.2×0.0×

Where this comes from

Calculated from KORU Medical Systems’s reported figures.

Based on the most recent quarter.

The official record: KORU Medical Systems’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's current ratio?
KORU Medical Systems (KRMD) reported current ratio of 2.3× in Q1 2026.
How has KORU Medical Systems's current ratio changed year-over-year?
KORU Medical Systems's current ratio decreased by 4.5% year-over-year, from 2.4× to 2.3×.
What is the long-term trend for KORU Medical Systems's current ratio?
Over 5 years (2020 to 2025), KORU Medical Systems's current ratio has grown at a -24.9% compound annual growth rate (CAGR), from 10.2× to 2.4×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.